![Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F3777.jpg&w=3840&q=50)
含有的纳米粒子PEGylation对通过FMRI对炎症成像的影响
Pascal Bouvain1,2, Jonas Schmitz3, Matthias Karg3,4
1Department of Molecular Cardiology, Experimental Cardiovascular Imaging, Heinrich Heine University, North Rhine-Westphalia, Universitätsstraße 1, 40225, Düsseldorf, Germany. pascal.bouvain@uni-duesseldorf.de.
Scientific reports
|November 29, 2025
概括
含纳米颗粒 (FNP) 的表面修饰影响其在炎症成像中的使用. 增加颗粒大小,而不是PEGylation,增强了特定的免疫细胞向,并减少了FMRI的背景信号.
科学领域:
- 纳米技术纳米技术
- 生物医学成像技术 生物医学成像技术
- 材料科学 材料科学 材料科学
背景情况:
- 含纳米粒子 (FNP) 对于使用-19磁共振成像 (F MRI) 的炎症成像非常有价值,因为它们的生物相容性和追踪免疫细胞的能力.
- FNPs的表面PEGylation通常用于减少细胞吸收和延长血液半衰期,但它对体内炎症成像疗效的影响需要研究.
研究的目的:
- 调查FNP PEGylation在体内炎症成像中的有效性.
- 评估颗粒大小和PEGylation对免疫细胞FNP吸收及其信号在FMRI中的影响.
主要方法:
- 不同大小的FNP和PEG化FNP (PEGFNP) 的合成和表征.
- 用流细胞计量评估各种细胞系和全血中的细胞吸收.
- 在活体中对小鼠的脂聚糖 (LPS) 诱导炎症模型进行成像,使用FMRI在静脉注射FNP或PEG后.
主要成果:
- 在实验室中,PEGylation显著降低了巨细胞和血液免疫细胞的FNP吸收.
- 在体内19FMRI显示在炎症组织中小FNP和PEGFNP的信号强度相似,表明混合信号来源.
- 较大的FNP在炎症组织中显示出较高的F信号,与较大的PEG FNP相比,表明尺寸依赖的向.
结论:
- 增加FNP大小可以消除炎症病变中的非特异性积累,并增强免疫细胞的细胞化.
- 较大的FNP产生特定的,依赖于免疫细胞的FMRI信号,背景最小,改善炎症成像对比度.
- 颗粒大小是优化FNP的关键因素,用于通过FMRI进行向性炎症成像.
相关概念视频
01:24Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
01:14Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).